# Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer Surgery

> **NCT04275661** · PHASE2 · COMPLETED · sponsor: **Assiut University** · enrollment: 60 (actual)

## Conditions studied

- Analgesia
- Breast Cancer

## Interventions

- **PROCEDURE:** Ultrasound (US) bi-level erector spinae block
- **DRUG:** levobupivacaine
- **DRUG:** Ketamine
- **DRUG:** Magnesium Sulfate

## Key facts

- **NCT ID:** NCT04275661
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-04-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04275661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04275661, "Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer Surgery". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT04275661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*